openPR Logo
Press release

Rna Interference Drug Delivery Market Estimated to Record Highest CAGR by 2021

01-04-2018 12:55 PM CET | Health & Medicine

Press release from: Persistence Market Research

Rna Interference Drug Delivery Market Estimated to Record

RNAi is one of the most important methods of analyzing gene functions in eukaryotes. It also plays a pivotal role in development of therapeutic gene silencing. Gene silencing is a term refers to the ability of a cell to prevent the expression of a specific gene.

RNAi has application in the areas of therapeutics, drug delivery, research and development and agriculture. The therapeutics application of RNAi includes metabolic disorders, cardiology, neurology, oncology and ophthalmology.

The global RNAi market is categorized based on various types of drug delivery technologies and by therapeutic application. The drug delivery segment is further sub-segmented into nanoparticle drug delivery technology, pulmonary drug delivery technology, nucleic acid drug delivery technology and aptamer drug delivery technology. Nanoparticle drug delivery technology is the largest sub-segment in global RNAi drug delivery market. However, aptamer drug delivery technology is the fastest growing sub-segment in global RNAi drug delivery market.

Request Report for TOC @ https://www.persistencemarketresearch.com/toc/3511

Therapeutic segment includes infectious diseases, cardiology, oncology, neurology, ophthalmology and metabolic disorders.

In terms of geographic, North America and Europe dominates the global RNAi drug delivery market. This is due to improved life science research infrastructures in these regions. The U.S. represents the largest market for RNAi drug delivery technologies followed by Canada in North America. In Europe, France, Germany, Spain and the U.K. holds major share of RNAi drug delivery market. However, Asia is expected to show high growth rates in the next five years in global RNAi drug delivery market due to increased investment by major companies in the region. Japan, China and India are expected to be the fastest growing RNAi drug delivery markets in Asia.

In recent time, increasing prevalence of diseases, such as cancer and cardiovascular diseases, and innovative applications of the drug delivery technologies are some of the major drivers of the global RNAi drug delivery market. For instance, aptamer drug delivery technology offers several advantages compared to protein and small-molecule drugs, such as low risk of side-effects and complications in humans and enhanced their drug like properties including improved stability and residence time in the bloodstream.

Request To Sample of Report @ https://www.persistencemarketresearch.com/samples/3511

In addition, increased research in the field of RNA therapeutics has also fueled the growth of global RNAi drug delivery market. However, high investment cost and stringent regulations are some of the major restraints for the global RNAi drug delivery market. In addition, targeted delivery of RNA molecules is key challenge for the global RNAi drug delivery market. Many companies engaged in developing RNA therapeutics are facing difficulties in delivery of RNA molecules to specific tissues to bring about a therapeutic effect. Increased research in the field of nanotechnology develops opportunity for the global RNAi drug delivery market. Increasing mergers and collaborations between life sciences companies and government research organizations is key trend for the global RNAi drug delivery market.

Some of the major companies operating in the global RNAi drug delivery market are Tekmira Pharmaceuticals Corp., Alnylam Pharmaceuticals Inc., Merck & Co. Inc., Isis Pharmaceuticals, Inc, Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Calondo Pharmaceuticals Inc., Marina Biotech Inc., RXi Pharmaceuticals Corp., Quark Pharmaceuticals Inc., Silence Therapeutics plc, Tacere Therapeutics Inc., PhaseRx Inc., Sirnaomics Inc., and Traversa Therapeutics Inc..

Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/3511

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rna Interference Drug Delivery Market Estimated to Record Highest CAGR by 2021 here

News-ID: 885267 • Views:

More Releases from Persistence Market Research

Microelectronic Medical Implants Market Size to Hit USD 98.5 Billion in 2032, expanding at a CAGR of 8.5% | PMR Report
Microelectronic Medical Implants Market Size to Hit USD 98.5 Billion in 2032, ex …
The microelectronic medical implants market plays a pivotal role in advancing modern healthcare by integrating electronics into medical devices to restore or enhance physiological functions. These implants are widely used in cardiology, neurology, orthopedics, and sensory assistance, including pacemakers, cochlear implants, neurostimulators, and insulin pumps. By offering precise monitoring, stimulation, and drug delivery, microelectronic implants significantly improve patient outcomes, quality of life, and long-term disease management. Request a Sample: https://www.persistencemarketresearch.com/samples/33122 According to
Dental Adhesives Market Worth US$ 4,052.8 Million By 2032, PMR Report
Dental Adhesives Market Worth US$ 4,052.8 Million By 2032, PMR Report
The dental adhesives market plays a critical role in modern dentistry by improving the durability, effectiveness, and esthetic outcomes of restorative and preventive dental procedures. Dental adhesives are extensively used in applications such as composite restorations, dental sealants, orthodontic bonding, and prosthodontics. They enhance adhesion between dental tissues and restorative materials, ensuring long-lasting results while minimizing microleakage, sensitivity, and secondary caries. Request a Sample: https://www.persistencemarketresearch.com/samples/33315 According to the latest study by Persistence
Wound Sprays Market Set to Soar to $694.5 Million by 2032 , Persistence Market Research,Inc
Wound Sprays Market Set to Soar to $694.5 Million by 2032 , Persistence Market R …
The wound sprays market plays a crucial role in modern healthcare by providing rapid, convenient, and effective solutions for wound management. Wound sprays are extensively used in hospitals, clinics, emergency care, and home healthcare settings to prevent infections, accelerate healing, and improve patient comfort. They are particularly valuable for cuts, abrasions, burns, surgical incisions, and chronic wounds. Request a Sample: https://www.persistencemarketresearch.com/samples/33306 According to the latest study by Persistence Market Research, The global
Surgical Instrument Tracking System Market Poised for 14.2% CAGR Growth by 2033
Surgical Instrument Tracking System Market Poised for 14.2% CAGR Growth by 2033
The surgical instrument tracking system market plays a pivotal role in enhancing the efficiency, safety, and accountability of surgical operations. These systems are widely deployed in hospitals, surgical centers, and clinics to manage surgical instruments, monitor their usage, and ensure sterilization compliance. By providing real-time tracking and inventory management, surgical instrument tracking systems reduce operational errors, prevent infections, and streamline surgical workflows. For More Information: https://www.persistencemarketresearch.com/market-research/surgical-instrument-tracking-system-market.asp According to the latest study by Persistence

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may